Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-11-001808
Filing Date
2011-01-11
Accepted
2011-01-11 18:59:43
Documents
1
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v207806_ex.html 5  
1 v207806_ex.xml 5 3774
  Complete submission text file 0001144204-11-001808.txt   5655
Mailing Address 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO, CA 92121
Business Address 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO, CA 92121 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Issuer) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIO-QUANT, INC. 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO CA 92121
Business Address
Damaj Bassam (Reporting) CIK: 0001478733 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-22245 | Film No.: 11524058